Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

BTD

😃Good
Catalog No. T37763Cas No. 896684-04-1

BTD is a selective transient receptor potential classical 5 (TRPC5) activator, which activates heteromeric channel complexes formed by TRPC5 and its recent relatives TRPC1 or TRPC4, used for studying neurodegenerative diseases.

BTD

BTD

😃Good
Catalog No. T37763Cas No. 896684-04-1
BTD is a selective transient receptor potential classical 5 (TRPC5) activator, which activates heteromeric channel complexes formed by TRPC5 and its recent relatives TRPC1 or TRPC4, used for studying neurodegenerative diseases.
Pack SizePriceAvailabilityQuantity
2 mg$48 5 days
Bulk & Custom
Add to Cart
Questions
View More
Select Batch
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
BTD is a selective transient receptor potential classical 5 (TRPC5) activator, which activates heteromeric channel complexes formed by TRPC5 and its recent relatives TRPC1 or TRPC4, used for studying neurodegenerative diseases.
Targets&IC50
TRPC5:1.4 μM (EC50)
In vitro
BTD can activate TRPC5 with EC50 values of 1.4 μM (fluorescence microporous Ca2+ analysis) and 1.3 μM (in whole-cell patch-clamp experiments).
BTD can activate TRPM8-expressing HEK293 cells with an EC50 value of 20.6 μM.
BTD can activate the heteropolymeric channel complex composed of TRPC5 and its close relatives, TRPC1 or TRPC4. [1]
BTD treatment down-regulates TRPC5 expression by increasing the activity of protein kinase C, thereby down-regulating downstream pain markers (CAMKII, ERK) in the spinal cord. [2]
In vivo
BTD (1 and 3 mg/kg intraperitoneally injected for 14 days) improved mechanical pain in diabetic neuropathic rats, but did not improve hypothermia or neurological deficits. [2]
Chemical Properties
Molecular Weight459.6
FormulaC24H33N3O4S
Cas No.896684-04-1
SmilesO=C(NCCCOC12CC3CC(CC(C3)C1)C2)CCC4=NS(=O)(=O)C5=CC=C(C=C5N4)C
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 80 mg/mL (174.06 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.1758 mL10.8790 mL21.7581 mL108.7903 mL
5 mM0.4352 mL2.1758 mL4.3516 mL21.7581 mL
10 mM0.2176 mL1.0879 mL2.1758 mL10.8790 mL
20 mM0.1088 mL0.5440 mL1.0879 mL5.4395 mL
50 mM0.0435 mL0.2176 mL0.4352 mL2.1758 mL
100 mM0.0218 mL0.1088 mL0.2176 mL1.0879 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy BTD | purchase BTD | BTD cost | order BTD | BTD chemical structure | BTD in vivo | BTD in vitro | BTD formula | BTD molecular weight